Losses continue to pile up at Smiths Falls-based Canopy Growth even as the licensed cannabis producer rapidly grows its revenues from legal cannabis sales, according to the firm’s quarterly earnings released after markets closed on Wednesday.
The Ottawa-area company reported revenues of $103.4 million for the three months ended June 30, nearly four times the company’s sales from the same quarter a year earlier – before recreational cannabis became legal for sale in Canada.
Net losses, meanwhile, ballooned as the company spent heavily on R&D, increased production capacity and positioned itself for further global expansion. Canopy reported a net loss of $1.28 billion for the quarter, compared with roughly $91 million last year.
OBJ360 (Sponsored)
Public-private collaboration is Canada’s innovation engine — but it needs fuel
Fidus Systems Inc.’s selection last year as AMD Adaptive Compute Partner of the Year is a reflection of the world-class talent the company has assembled in Ottawa. As the first
ExecHealth brings Canada’s leading advanced longevity program to National Capital Region
Ottawa’s ExecHealth was one of the first private clinics in Canada to provide personalized, ongoing primary care, having opened its doors 20 years ago this year. Now the pioneering local
Canopy’s sizeable losses frustrated investor Constellation Brands last quarter, which reported a loss of its own in part due to the cannabis firm’s performance. Bruce Linton was subsequently ousted as co-CEO of the company.
Chief executive Mark Zekulin will discuss the company’s earnings on a call with analysts Thursday morning.
